NGNE insider trading
NasdaqGM HealthcareNeurogene Inc.: insider trade history from SEC Form 4 filings.
About Neurogene Inc.
Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreements with The University of Edinburgh, Virovek, Inc., Sigma-Aldrich Co. LLC., and Leland Stanford Junior University. The company was founded in 2018 and is headquartered in New York, New York.
Company website: www.neurogene.com
NGNE insider activity at a glance
FilingIQ tracks 36 insider transactions for NGNE in filings since Mar 14, 2024. The most recent transaction is dated Sep 22, 2026.
Across the full history, 6 open-market purchases
and 19 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on NGNE insider trades is 47.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest NGNE Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading NGNE
Frequently asked
- How many insider trades does FilingIQ track for NGNE?
- FilingIQ tracks 36 Form 4 insider transactions for NGNE (Neurogene Inc.), covering filings from Mar 14, 2024 onwards. 1 of those are dated within the last 90 days.
- Are NGNE insiders net buyers or net sellers?
- Across the full Form 4 history for NGNE, 6 transactions (17%) were open-market purchases and 19 (53%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does NGNE insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is NGNE in?
- Neurogene Inc. (NGNE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $304.84M.
Methodology & sources
Every NGNE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.